Literature DB >> 1653564

Efficacy of Australian vaccines against recent isolates of avian infectious bronchitis viruses.

Y Arvidson1, G A Tannock, M Zerbes, J Ignjatovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1653564     DOI： 10.1111/j.1751-0813.1991.tb03198.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN： 0005-0423            Impact factor:   1.281


× No keyword cloud information.
  4 in total

1.  Protection conferred by a recombinant Marek's disease virus that expresses the spike protein from infectious bronchitis virus in specific pathogen-free chicken.

Authors:  Xiaorong Zhang; Yantao Wu; Yezhen Huang; Xiufan Liu
Journal:  Virol J       Date:  2012-05-04       Impact factor: 4.099

2.  Development of attenuated vaccines from Taiwanese infectious bronchitis virus strains.

Authors:  Yuan-Pin Huang; Ching-Ho Wang
Journal:  Vaccine       Date:  2005-09-07       Impact factor: 3.641

3.  Evaluation of the protection conferred by commercial vaccines and attenuated heterologous isolates in China against the CK/CH/LDL/97I strain of infectious bronchitis coronavirus.

Authors:  Shengwang Liu; Xiaonan Zhang; Yu Wang; Chengren Li; Qiaoran Liu; Zongxi Han; Qinxia Zhang; Xiangang Kong; Guangzhi Tong
Journal:  Vet J       Date:  2007-11-01       Impact factor: 2.688

4.  Full genome analysis of Australian infectious bronchitis viruses suggests frequent recombination events between vaccine strains and multiple phylogenetically distant avian coronaviruses of unknown origin.

Authors:  José A Quinteros; Sang-Won Lee; Philip F Markham; Amir H Noormohammadi; Carol A Hartley; Alistair R Legione; Mauricio J C Coppo; Paola K Vaz; Glenn F Browning
Journal:  Vet Microbiol       Date:  2016-11-06       Impact factor: 3.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.